Barclays »

Harpoon Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Harpoon Therapeutics shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Harpoon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Harpoon Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Harpoon Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $999 105 9.52

More positions owned by Barclays

Invesco Qqq Tr Opt Call Option (QQQ)
SPDR S&ampP 500 ETF TR Opt Put Option (SPY)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple (AAPL)
Amazon Opt Call Option (AMZN)
Alphabet Opt Put Option (GOOGL)
NVIDIA Corporation (NVDA)
Tesla Opt Put Option (TSLA)
Meta Platforms Opt Put Option (META)
Ishares Tr Fund (HYG)
Alphabet Opt Call Option (GOOG)
Visa Opt Put Option (V)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)

View all positions for Barclays

Top funds holding Harpoon Therapeutics

Cormorant Asset Management
Commodore Capital
RA Capital Management
Franklin Resources
Artal Group
Vanguard Group
Soleus Capital Management
Blackstone Group
Citadel Advisors
Lion Point Capital
Kennedy Capital Management
Goldman Sachs Group
Citigroup
Two Sigma Investments
Standard Life Aberdeen

View all funds holding Harpoon Therapeutics